DB
AZN icon

Danske Bank’s AstraZeneca AZN Stock Holding History

Danske Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,723
Closed -$253K – 1528
2025
Q1 		$253K Buy
+1,723
New +$249K ﹤0.01% 913
2024
Q2 		– Sell
-40,115
Closed -$5.44M – 1160
2024
Q1 		$5.44M Buy
+40,115
New +$5.31M 0.02% 554

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Danske Bank's AZN Position: Q2 2025 in Review

Danske Bank sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 1,723 shares — an estimated $253K sold.

Danske Bank first reported a position in AZN in Q1 2024 and held it in 2 quarters. The position peaked at $5.44M in Q1 2024. 1,223 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

  • Danske Bank reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
  • Danske Bank sold 1,723 AstraZeneca shares in Q2 2025, an estimated $253K.
  • Danske Bank first reported a position in AstraZeneca in Q1 2024 and held it in 2 quarters.
  • Danske Bank's AstraZeneca position peaked at $5.44M in Q1 2024.
  • 1,223 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on Danske Bank's 13F filing for Q2 2025, filed 18 Dec 2025.